Skip to Content

Matching Articles

Back to the Disease Index

Neurology: Lennox-Gastaut Syndrome

Results 1 to 1 of 1 articles.

Clobazam (Onfi) for Lennox-Gastaut Syndrome

The Medical Letter on Drugs and Therapeutics • Mar 05, 2012 (Issue 1385)
Clobazam (Onfi – Lundbeck), an oral benzodiazepine, has been approved by the FDA for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients ≥2 years old. It has been available in Canada (Frisium) and other countries for years for treatment of anxiety and many types of epilepsy.
http://secure.medicalletter.org/TML-article-1385b | Show Introduction Hide Introduction